MIRA
INFORM REPORT
|
Report Date : |
01.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
KOEI CHEMICAL COMPANY, LIMITED |
|
|
|
|
Registered Office : |
2-12-13, Hanaten-Nishi, Joto-ku, Osaka-Shi, 536-0011 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2012 |
|
|
|
|
Date of Incorporation : |
17.06.1917 |
|
|
|
|
Legal Form : |
Public Subsidiary |
|
|
|
|
Line of Business : |
manufacture
and sale of chemical products |
|
|
|
|
No. of Employees : |
342 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
japan - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation, a
strong work ethic, mastery of high technology, and a comparatively small
defense allocation (1% of GDP) helped Japan develop a technologically advanced
economy. Two notable characteristics of the post-war economy were the close
interlocking structures of manufacturers, suppliers, and distributors, known as
keiretsu, and the guarantee of lifetime employment for a substantial portion of
the urban labor force. Both features are now eroding under the dual pressures
of global competition and domestic demographic change. Japan's industrial
sector is heavily dependent on imported raw materials and fuels. A tiny
agricultural sector is highly subsidized and protected, with crop yields among
the highest in the world. Usually self-sufficient in rice, Japan imports about
60% of its food on a caloric basis. Japan maintains one of the world's largest
fishing fleets and accounts for nearly 15% of the global catch. For three decades,
overall real economic growth had been spectacular - a 10% average in the 1960s,
a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed
markedly in the 1990s, averaging just 1.7%, largely because of the after
effects of inefficient investment and an asset price bubble in the late 1980s
that required a protracted period of time for firms to reduce excess debt,
capital, and labor. Measured on a purchasing power parity (PPP) basis that
adjusts for price differences, Japan in 2011 stood as the fourth-largest
economy in the world after second-place China, which surpassed Japan in 2001,
and third-place India, which edged out Japan in 2011. A sharp downturn in
business investment and global demand for Japan's exports in late 2008 pushed
Japan further into recession. Government stimulus spending helped the economy
recover in late 2009 and 2010, but the economy contracted again in 2011 as the
massive 9.0 magnitude earthquake in March disrupted manufacturing. Electricity
supplies remain tight because Japan has temporarily shut down almost all of its
nuclear power plants after the Fukushima Daiichi nuclear reactors were crippled
by the earthquake and resulting tsunami. Estimates of the direct costs of the
damage - rebuilding homes, factories, and infrastructure - range from $235
billion to $310 billion, and GDP declined almost 0.5% in 2011. Prime Minister
Yoshihiko NODA has proposed opening the agricultural and services sectors to
greater foreign competition and boosting exports through membership in the
US-led Trans-Pacific Partnership trade talks and by pursuing free-trade
agreements with the EU and others, but debate continues on restructuring the
economy and reining in Japan's huge government debt, which exceeds 200% of GDP.
Persistent deflation, reliance on exports to drive growth, and an aging and
shrinking population are other major long-term challenges for the economy.
|
Source
: CIA |
Company name & address
KOEI CHEMICAL
COMPANY, LIMITED
2-12-13, Hanaten-Nishi, Joto-ku
Osaka-Shi, 536-0011
Japan
Tel: 81-6-69610252
Fax: 81-6-69610498
Web: www.koeichem.com
Syntheiss
Employees: 342
Company Type: Public Subsidiary
Corporate Family: 131
Companies
Ultimate Parent: Sumitomo
Chemical Co Ltd
Traded: Osaka
Stock Exchange: 4367
Incorporation Date:
17-Jun-1917
Auditor: KPMG AZSA LLC
Financials in: USD
(Millions)
Fiscal Year End:
31-Mar-2012
Reporting Currency: Japanese
Yen
Annual Sales: 249.6
1
Net Income: 2.0
Total Assets: 266.9
2
Market Value: 51.6
(15-Feb-2013)
Business Description
KOEI CHEMICAL COMPANY, LIMITED is a Japan-based company engaged in the manufacture and sale of chemical products. The Company operates in two business divisions. The Fine Chemical division handles pharmaceutical- and agricultural-related chemicals. This segment also manufactures and sells functional chemicals, including catalytic agent, solvents, resin, macromolecular additives, photographic chemicals, and information technology (IT) related chemicals. The Chemical Product division handles polyalcohol products and multiple formaldehyde products, which are used in paints and synthetic resins. As of March 31, 2012, the Company had two subsidiaries and one parent company. For the nine months ended 31 December 2012, KOEI CHEMICAL COMPANY, LIMITED revenues decreased 15% to Y11.8B. Net loss applicable to common stockholders totaled Y406.9M vs. income of Y37.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Fine Products Division segment loss totaling Y259.6M vs. income of Y71.7M, Chemicals Division segment loss increase of 89% to Y66.1M.
Industry
Industry Chemical Manufacturing
ANZSIC 2006: 1812 - Basic
Organic Chemical Manufacturing
NACE 2002: 2414 - Manufacture
of other organic basic chemicals
NAICS 2002: 325199 - All Other
Basic Organic Chemical Manufacturing
UK SIC 2003: 2414 - Manufacture
of other organic basic chemicals
UK SIC 2007: 2014 - Manufacture
of other organic basic chemicals
US SIC 1987: 2869 - Industrial
Organic Chemicals, Not Elsewhere Classified
Key Executives
|
Name |
Title |
|
Naoya Kanda |
President, Executive President, Representative Director |
|
Akihiko Hamabe |
Manager of Accounting Office |
|
Atsuro Kadota |
Managing Executive Officer |
|
Akihiko Ohta |
Executive officer |
|
Kiyotaka Ishiuchi |
Executive Officer, Chief Director of Production & Technology,
Director |
Significant Developments
|
* number of significant developments within the last 12 months
News
|
Financial Summary
|
Stock Snapshot
|
1 - Profit & Loss Item Exchange Rate: USD 1 = JPY 78.96121
2 - Balance Sheet Item Exchange Rate: USD 1 = JPY 82.38536
Corporate Overview
Location
2-12-13, Hanaten-Nishi, Joto-ku
Osaka-Shi, 536-0011
Japan
Tel: 81-6-69610252
Fax: 81-6-69610498
Web: www.koeichem.com
Quote Symbol - Exchange
4367 - Osaka Stock
Exchange
Sales JPY(mil): 19,712.5
Assets JPY(mil): 21,990.1
Employees: 342
Fiscal Year End: 31-Mar-2012
Industry: Chemical
Manufacturing
Incorporation Date: 17-Jun-1917
Company Type: Public
Subsidiary
Quoted Status: Quoted
President,
Executive President, Representative Director:
Naoya Kanda
Industry Codes
ANZSIC 2006 Codes:
1812 - Basic Organic Chemical Manufacturing
NACE 2002 Codes:
2414 - Manufacture of other organic basic chemicals
NAICS 2002 Codes:
325199 - All Other Basic Organic Chemical Manufacturing
US SIC 1987:
2869 - Industrial Organic Chemicals, Not Elsewhere Classified
UK SIC 2003:
2414 - Manufacture of other organic basic chemicals
UK SIC 2007:
2014 - Manufacture of other organic basic chemicals
Business
Description
KOEI CHEMICAL
COMPANY, LIMITED is a Japan-based company engaged in the manufacture and sale
of chemical products. The Company operates in two business divisions. The Fine
Chemical division handles pharmaceutical- and agricultural-related chemicals.
This segment also manufactures and sells functional chemicals, including
catalytic agent, solvents, resin, macromolecular additives, photographic
chemicals, and information technology (IT) related chemicals. The Chemical
Product division handles polyalcohol products and multiple formaldehyde
products, which are used in paints and synthetic resins. As of March 31, 2012,
the Company had two subsidiaries and one parent company. For the nine months
ended 31 December 2012, KOEI CHEMICAL COMPANY, LIMITED revenues decreased 15%
to Y11.8B. Net loss applicable to common stockholders totaled Y406.9M vs.
income of Y37.9M. Revenues reflect a decrease in demand for the Company's
products and services due to unfavorable market conditions. Net loss reflects
Fine Products Division segment loss totaling Y259.6M vs. income of Y71.7M,
Chemicals Division segment loss increase of 89% to Y66.1M.
More Business
Descriptions
Production of polyhydric alcohol and related drugs particularly for use
in the treatment of AIDS
Mfr. of Chemicals
Koei Chemical Co.,
Ltd. (Koei Chemical) is occupied in the development, producing, distributing
and marketing of chemical products. Some of the key products of the company
include alkyl and cyclic amines, pyrazines, alkenyl pyridines and polymers,
pyridines and many more. The company offers product portfolio of more than 180
products in Asia, the US and Europe through its affiliate companies and
regional offices. Koei Chemical in coordination with its subsidiaries employs
over 350 people and operates through two business divisions namely, Fine
Chemicals division and Chemicals division. The Fine Chemicals Division segment
of the company carries out the developing and manufacturing agrochemical,
organic chemicals, and pharmaceutical related products including pyrazines such
as dimethylpyrazine, pyrazine carboxylic acid, methyl pyrazinecarboxylic acid,
pyrazinamide, cyano pyrazine, amino pyrazine, chloro pyrazine, dichloro
pyrazine and pyridines containing functional groups, ring compounds, and
heteroatoms in side-chains. The company offers amines such as amines containing
benzene ring, monoamines, diamines, and polyamines. The Chemicals Dvision
segment of the company deals in developing and manufacturing of polyols such as
pentaerythritol and trimethylolpropane. The company offers formalins and
derivatives of methanol. Moreover, Koei Chemical offers products such as
dipentaerythritol, used as a raw material for stabilizers, lubricants, paints,
and inks. The company’s research and development activities include the
development of new products in order to meet its clients’ requirements. The
company employs about 20% of its people in research and development for unique
technologies. In addition, the company is also determined in enhancing its
existing product lines. The company has its research and development facility
located at Osaka in Japan. The company operates across various states in Japan
through manufacturing facilities located at Chiba and Osaka and two key
affiliated companies namely, Koei Techno Co, Ltd, and Koei Perstorp Co, Ltd
located at Osaka and Tokyo.In June 2011, The company announced that it has
appointed Naoya Kanda, who is going to replace Shigehiro Ohba, as the new
president of the company.As per the fiscal year ended March,2012,the net
consolidated net sales of the Company was reported as ,the Fine Chemicals
division s reported 13,630m yen of sales and the chemical division declared
sales of 6,082m yen as compared to previous year of 13,280m yen and 6,669m yen
respectively.Moreover, net income for the Fiscal year ended March 2012 was
recorded as 159m yen as compared to 286m yen for the previous year.
Koei Chemical Co.,
Ltd. (Koei Chemical) is a chemicals manufacturing company, based in Japan. The company
operates through the developing, manufacturing, distributing and marketing
sectors of the various chemicals. Koei Chemicals manufactures and sells all
kinds of chemical products, especially polyhydric alcohols, pyridine bases,
pyrazines, and amines. Its key products include synthetic resins, formalins,
pyridines, pyrazines, polyols, and amines. The company's products find
applications in Surfactants, Rubber chemicals, Photographic chemicals,
Pharmaceuticals, Agrochemicals, Dyestuffs. It operates through two plants,
namely, Osaka and Chiba plants and one Research Laboratory in Japan. The
company provides more than 180 products. It was established 1917. Koei Chemical
is headquartered in Chuo-ku, Tokyo, Japan.The company reported revenues of
(Yen) JPY 19,712.47 million during the fiscal year ended March 2012, a decrease
of 1.19% from 2011. The operating profit of the company was JPY 257.88 million
during the fiscal year 2012, a decrease of 45.86% from 2011. The net profit of
the company was JPY 159.34 million during the fiscal year 2012, a decrease of
44.41% from 2011.
All Other Chemical
Product and Preparation Manufacturing
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|
|
|
Corporate Family |
Corporate
Structure News: |
|
|
Sumitomo
Chemical Co Ltd |
|
KOEI CHEMICAL COMPANY, LIMITED |
|
|
|
|
|
Company
Name |
Company
Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
Tokyo |
Japan |
Chemical Manufacturing |
24,668.9 |
29,839 |
|
|
|
Subsidiary |
Osaka-Shi |
Japan |
Biotechnology and Drugs |
4,437.6 |
7,601 |
|
|
|
Acquisition of
Boston Biomedical, Inc. proposed/announced.See corporate
structure news on
Sumitomo Chemical Co Ltd for details |
|||||||
|
Subsidiary |
Marlborough, MA |
United States |
Biotechnology and Drugs |
1,292.3 |
2,400 |
|
|
|
Subsidiary |
Windsor, NS |
Canada |
Biotechnology and Drugs |
|
33 |
|
|
|
Subsidiary |
London |
United Kingdom |
Biotechnology and Drugs |
4.9 |
15 |
|
|
|
Subsidiary |
San Diego, CA |
United States |
Biotechnology and Drugs |
6.3 |
7 |
|
|
|
Subsidiary |
Osaka, Osaka |
Japan |
Food Processing |
337.4 |
|
|
|
|
Subsidiary |
Suzhou |
China |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Healthcare Facilities |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Investment Services |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Business Services |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Fish and Livestock |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Iksan-si, Jeollabuk-do |
Korea, Republic of |
Chemical Manufacturing |
1,941.8 |
2,587 |
|
|
|
Subsidiary |
Marlborough, MA |
United States |
Biotechnology and Drugs |
|
2,400 |
|
|
|
Branch |
Fort Lee, NJ |
United States |
Biotechnology and Drugs |
129.5 |
130 |
|
|
|
Unit |
Niihama, Ehime |
Japan |
Chemical Manufacturing |
|
1,400 |
|
|
|
Subsidiary |
Osaka |
Japan |
Business Services |
187.3 |
1,095 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Business Services |
1.3 |
10 |
|
|
|
Subsidiary |
Ichihara, Chiba |
Japan |
Business Services |
|
800 |
|
|
|
Joint Venture |
Invercargill |
New Zealand |
Chemical Manufacturing |
517.6 |
750 |
|
|
|
Subsidiary |
Osaka-Shi |
Japan |
Chemical Manufacturing |
219.2 |
394 |
|
|
|
Subsidiary |
Chennai, Tamil Nadu |
India |
Chemical Manufacturing |
2.3 |
26 |
|
|
|
Affiliates |
Amagasaki-Shi |
Japan |
Chemical Manufacturing |
278.8 |
356 |
|
|
|
Subsidiary |
Oita, Oita |
Japan |
Chemical Manufacturing |
2.3 |
|
|
|
|
Subsidiary |
Osaka-Shi |
Japan |
Chemical Manufacturing |
249.6 |
342 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Chemicals - Plastics and Rubber |
1,332.1 |
323 |
|
|
|
Subsidiary |
Shanghai, Shanghai |
China |
Electronic Instruments and Controls |
117.1 |
300 |
|
|
|
Joint Venture |
Osaka |
Japan |
Chemicals - Plastics and Rubber |
|
300 |
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Fabricated Plastic and Rubber |
83.6 |
90 |
|
|
|
Subsidiary |
Osaka |
Japan |
Chemical Manufacturing |
|
300 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Chemical Manufacturing |
720.2 |
254 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Chemical Manufacturing |
446.1 |
200 |
|
|
|
Subsidiary |
Chiba |
Japan |
Engineering Consultants |
|
205 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Business Services |
20.9 |
45 |
|
|
|
Subsidiary |
Osaka |
Japan |
Chemical Manufacturing |
|
200 |
|
|
|
Facility |
Kurashiki, Okayama |
Japan |
Chemical Manufacturing |
|
190 |
|
|
|
Subsidiary |
Cambridge |
United Kingdom |
Business Services |
15.1 |
173 |
|
|
|
Subsidiary |
Cambridge |
United Kingdom |
Biotechnology and Drugs |
14.4 |
173 |
|
|
|
UK Branch/Trading address |
Huntingdon |
United Kingdom |
Biotechnology and Drugs |
14.4 |
300 |
|
|
|
Subsidiary |
London |
United Kingdom |
Business Services |
|
|
|
|
|
Subsidiary |
Cambridge |
United Kingdom |
Biotechnology and Drugs |
0.8 |
|
|
|
|
UK Branch/Trading address |
Kidlington |
United Kingdom |
Business Services |
|
|
|
|
|
Subsidiary |
Cambridge |
United Kingdom |
Business Services |
|
|
|
|
|
Subsidiary |
Marlborough, MA |
United States |
Biotechnology and Drugs |
|
130 |
|
|
|
Subsidiary |
Walnut Creek, CA |
United States |
Chemical Manufacturing |
135.8 |
120 |
|
|
|
Subsidiary |
Tokyo |
Japan |
Containers and Packaging |
|
120 |
|
|
|
Subsidiary |
Kaohsiung |
Taiwan |
Miscellaneous Fabricated Products |
|
120 |
|
|
|
Subsidiary |
Osaka |
Japan |
Chemical Manufacturing |
|
90 |
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
84 |
|
|
|
Subsidiary |
Milan |
Italy |
Chemical Manufacturing |
115.3 |
77 |
|
|
|
Subsidiary |
Saint Didier au Mont d'Or |
France |
Chemical Manufacturing |
88.7 |
77 |
|
|
|
Subsidiary |
Osaka |
Japan |
Business Services |
|
70 |
|
|
|
Subsidiary |
Ho Chi Minh City |
Viet Nam |
Chemical Manufacturing |
|
70 |
|
|
|
Subsidiary |
Minneapolis, MN |
United States |
Chemical Manufacturing |
36.6 |
60 |
|
|
|
Subsidiary |
Osaka |
Japan |
Chemicals - Plastics and Rubber |
|
60 |
|
|
|
Subsidiary |
Hefei, Anhui |
China |
Chemical Manufacturing |
3.8 |
50 |
|
|
|
Subsidiary |
Dusseldorf |
Germany |
Chemical Manufacturing |
|
50 |
|
|
|
Subsidiary |
Machelen (Bt.) |
Belgium |
Chemical Manufacturing |
420.5 |
46 |
|
|
|
Subsidiary |
Shanghai |
China |
Chemical Manufacturing |
|
48 |
|
|
|
Subsidiary |
Barcelona |
Spain |
Chemical Manufacturing |
35.9 |
47 |
|
|
|
Subsidiary |
Griffin, GA |
United States |
Chemicals - Plastics and Rubber |
2.4 |
45 |
|
|
|
Subsidiary |
Tokyo |
Japan |
Containers and Packaging |
|
40 |
|
|
|
Subsidiary |
Saint Didier au Mont d'Or |
France |
Chemical Manufacturing |
89.5 |
34 |
|
|
|
Subsidiary |
Seremban, Negeri Sembilan |
Malaysia |
Chemical Manufacturing |
9.0 |
30 |
|
|
|
Subsidiary |
Mumbai |
India |
Chemical Manufacturing |
|
30 |
|
|
|
Subsidiary |
Sao Paulo, Sao Paulo |
Brazil |
Chemical Manufacturing |
11.5 |
27 |
|
|
|
Subsidiary |
Osaka |
Japan |
Chemical Manufacturing |
|
27 |
|
|
|
Subsidiary |
Phoenix, AZ |
United States |
Semiconductors |
3.9 |
25 |
|
|
|
Subsidiary |
Epping, NSW |
Australia |
Chemical Manufacturing |
1.7 |
24 |
|
|
|
Subsidiary |
Tokyo |
Japan |
Electronic Instruments and Controls |
|
20 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Chemical Manufacturing |
1,819.8 |
16 |
|
|
|
Subsidiary |
London |
United Kingdom |
Chemical Manufacturing |
37.4 |
14 |
|
|
|
Subsidiary |
London |
United Kingdom |
Business Services |
0.6 |
15 |
|
|
|
Subsidiary |
New York, NY |
United States |
Chemical Manufacturing |
|
13 |
|
|
|
Subsidiary |
Pretoria |
South Africa |
Chemical Manufacturing |
|
12 |
|
|
|
Subsidiary |
Taipei |
Taiwan |
Business Services |
|
3 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Insurance (Accident and Health) |
|
3 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Chemical Manufacturing |
2,120.4 |
|
|
|
|
Subsidiary |
Tainan |
Taiwan |
Scientific and Technical Instruments |
567.0 |
|
|
|
|
Subsidiary |
Chuo-Ku, Tokyo |
Japan |
Software and Programming |
115.3 |
|
|
|
|
Subsidiary |
Chiyoda-Ku, Tokyo |
Japan |
Fabricated Plastic and Rubber |
110.5 |
|
|
|
|
Subsidiary |
Chuo-Ku, Tokyo |
Japan |
Chemicals - Plastics and Rubber |
86.2 |
|
|
|
|
Subsidiary |
Chuo-Ku, Tokyo |
Japan |
Paper and Paper Products |
71.7 |
|
|
|
|
Subsidiary |
Kudamatsu, Yamaguchi |
Japan |
Chemical Manufacturing |
67.5 |
|
|
|
|
Subsidiary |
Oita, Oita |
Japan |
Business Services |
18.4 |
|
|
|
|
Subsidiary |
Osaka |
Japan |
Chemicals - Plastics and Rubber |
|
|
|
|
|
Subsidiary |
Samut Prakan |
Thailand |
Chemicals - Plastics and Rubber |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Electric Utilities |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Construction Services |
50.8 |
|
|
|
|
Subsidiary |
St Didier Au Mont D Or |
France |
Commercial Banks |
|
|
|
|
|
Subsidiary |
Bangkok |
Thailand |
Fabricated Plastic and Rubber |
|
|
|
|
|
Subsidiary |
Shenzhen |
China |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Zhuhai, Guangdong |
China |
Chemical Manufacturing |
|
|
|
|
|
Unit |
Ichihara, Chiba |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Facility |
Gifu |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Unit |
Niihama, Ehime |
Japan |
Fabricated Plastic and Rubber |
|
|
|
|
|
Unit |
Oita |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Construction Services |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Miscellaneous Transportation |
|
|
|
|
|
Subsidiary |
Ichihara, Chiba |
Japan |
Water Utilities |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Miscellaneous Fabricated Products |
|
|
|
|
|
Subsidiary |
Takarazuka, Hyogo |
Japan |
Business Services |
|
|
|
|
|
Facility |
Yamagata |
Japan |
Electronic Instruments and Controls |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Business Services |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Nishinomiya, Hyogo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Investment Services |
|
|
|
|
|
Subsidiary |
Hong Kong |
Hong Kong |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Fukuoka |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Lysomice |
Poland |
Electronic Instruments and Controls |
|
|
|
|
|
Unit |
Misawa, Aomori |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Niihama, Ehime |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Shanghai |
China |
Electronic Instruments and Controls |
|
|
|
|
|
Subsidiary |
Amsterdam |
Netherlands |
Consumer Financial Services |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Business Services |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Shanghai |
China |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Personal Services |
|
|
|
|
|
Subsidiary |
Dalian, Liaoning |
China |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Osaka |
Japan |
Real Estate Operations |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Dalian, Liaoning |
China |
Chemical Manufacturing |
|
|
|
|
|
Unit |
Osaka |
Japan |
Chemical Manufacturing |
|
|
|
|
Competitors Report
|
Company
Name |
Location |
Employees |
Ownership |
|
DAISO CO., LTD. |
Osaka-Shi, Japan |
755 |
Public |
|
Nippon Soda Co., Ltd. |
Tokyo, Japan |
2,507 |
Public |
|
Shin-Etsu Chemical Co Ltd |
Tokyo, Japan |
16,167 |
Public |
|
Toagosei Co Ltd |
Tokyo, Japan |
2,534 |
Public |
|
Tokuyama Corporation |
Tokyo, Japan |
1,044 |
Public |
Executive report
|
Board of
Directors |
|
|
|
|
||||||
|
Executive Officer, Chief Director of Production & Technology,
Director |
Director/Board Member |
|
||||||
|
|||||||||
|
President, Executive President, Representative Director |
Director/Board Member |
|
|
|||||
|
|||||||||
|
Managing Executive Officer, President of Subsidiary, Director |
Director/Board Member |
|
|
|||||
|
|||||||||
|
Independent Director |
Director/Board Member |
|
|
|||||
|
|||||||||
|
Senior Managing Executive Officer, Chief Director of Research and
Development, Manager of Development Office in Main Research and Development
Unit, Director |
Director/Board Member |
|
|
|||||
|
|||||||||
|
Managing Executive Officer, Director |
Director/Board Member |
|
|
|||||
|
|||||||||
|
Executives |
|
|
|
|
||||||
|
President, Executive President, Representative Director |
President |
|
||||||
|
|||||||||
|
Managing Executive Officer |
Managing Director |
|
|
|||||
|
|||||||||
|
Manager of Accounting Office |
Other |
|
|
|||||
|
Executive Officer, Plant Manager of Main Production and Technology
Unit |
Other |
|
|
|||||
|
Executive Officer, Director of Research Institute in Main Research
Development Unit |
Other |
|
|
|||||
|
Executive officer |
Other |
|
|
|||||
|
|||||||||
Significant Developments
KOEI CHEMICAL CO
LTD Lowers Full-year Consolidated Outlook for FY 2013 Jan 31, 2013
KOEI CHEMICAL CO
LTD announced that it has lowered its full-year consolidated outlook for
revenue from JPY 20,900 million to JPY 19,000 million, operating profit (loss)
from JPY 270 million to JPY (440 million), ordinary profit (loss) from JPY 310
million to JPY (300 million), net profit (loss) from JPY 200 million to JPY
(200 million), and earnings (loss) per share from JPY 8.17 to JPY (8.17), for
the fiscal year ending March 31, 2013. The Company lowered its full-year
consolidated outlook mainly due to the delay of delivery of large-scale
pharmaceutical intermediates and weak demands for electronic and display
materials.
KOEI CHEMICAL CO LTD Lowers Mid-year and Full-year Consolidated Outlook and Amends Year-end Dividend Forecast for FY 2013 Oct 12, 2012
KOEI CHEMICAL CO LTD announced that it has lowered its mid-year consolidated outlook for revenue from JPY 9,000 million to JPY 8,150 million, operating profit (loss) from JPY (50 million) to JPY (330 million), ordinary profit (loss) from JPY 0 million to JPY (330 million), net profit (loss) from JPY 0 million to JPY (230 million), and earnings (loss) per share from JPY 0.00 to JPY (9.40), for the fiscal year ending March 31, 2013. The Company also has lowered its full-year consolidated outlook for revenue from JPY 21,500 million to JPY 20,900 million, operating profit from JPY 340 million to JPY 270 million, ordinary profit from JPY 420 million to JPY 310 million, net profit from JPY 270 million to JPY 200 million, and earnings per share from JPY 11.03 to JPY 8.17, for the fiscal year ending March 31, 2013. The Company lowered its mid-year and full-year consolidated outlook mainly due to the decrease in demands from electronic related area. The Company also has amended its year-end dividend forecast from JPY 7.00 per share, which was announced on May 10, 2012, to an undetermined value, for the same fiscal year.
Koei Chemical Company, Ltd. Lowers Consolidated Full-year Forecast for FY 2012; Lowers Year-end Dividend Forecast for FY 2012 Apr 13, 2012
Koei Chemical Company, Ltd. announced that it has lowered the consolidated full-year forecast for revenue from JPY 21,000 million to JPY 19,700 million, operating profit from JPY 430 million to JPY 280 million, ordinary profit from JPY 440 million to JPY 380 million, net profit from JPY 280 million to JPY 150 million and earning per share from JPY 11.44 to JPY 6.13 for the fiscal year ended March 31, 2012. The Company lowered the consolidated full-year outlook due to raising value of yen, slump in demand and increased tax.
Annual
Income Statement
Financials in: USD (mil)
Except for share items (millions) and per share items (actual units)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
12 Months |
12 Months |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate
(Period Average) |
78.961215 |
85.691434 |
92.941082 |
100.484331 |
114.302336 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Net Sales |
249.6 |
232.8 |
221.7 |
234.7 |
218.9 |
|
Revenue |
249.6 |
232.8 |
221.7 |
234.7 |
218.9 |
|
Total Revenue |
249.6 |
232.8 |
221.7 |
234.7 |
218.9 |
|
|
|
|
|
|
|
|
Cost of Revenue |
205.9 |
189.2 |
179.2 |
187.4 |
172.5 |
|
Cost of Revenue, Total |
205.9 |
189.2 |
179.2 |
187.4 |
172.5 |
|
Gross Profit |
43.8 |
43.6 |
42.5 |
47.3 |
46.4 |
|
|
|
|
|
|
|
|
Selling/General/Administrative Expense |
18.3 |
19.2 |
18.1 |
16.6 |
15.5 |
|
Labor & Related Expense |
10.8 |
9.0 |
8.5 |
8.1 |
6.6 |
|
Total Selling/General/Administrative Expenses |
29.2 |
28.2 |
26.6 |
24.7 |
22.0 |
|
Research & Development |
10.7 |
9.5 |
10.2 |
9.0 |
7.8 |
|
Depreciation |
0.3 |
- |
- |
- |
- |
|
Depreciation/Amortization |
0.3 |
- |
- |
- |
- |
|
Impairment-Assets Held for Use |
0.2 |
0.3 |
0.8 |
3.0 |
4.0 |
|
Impairment-Assets Held for Sale |
0.1 |
0.0 |
- |
- |
- |
|
Other Unusual Expense (Income) |
- |
- |
- |
- |
0.0 |
|
Unusual Expense (Income) |
0.3 |
0.3 |
0.8 |
3.0 |
4.0 |
|
Other Operating Expense |
0.0 |
- |
- |
- |
- |
|
Other Operating Expenses, Total |
0.0 |
- |
- |
- |
- |
|
Total Operating Expense |
246.4 |
227.3 |
216.8 |
224.1 |
206.3 |
|
|
|
|
|
|
|
|
Operating Income |
3.3 |
5.6 |
4.9 |
10.6 |
12.6 |
|
|
|
|
|
|
|
|
Interest Expense -
Non-Operating |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
Interest Expense, Net Non-Operating |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
Interest Income -
Non-Operating |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Investment Income -
Non-Operating |
0.8 |
-0.3 |
0.4 |
-0.3 |
0.4 |
|
Interest/Investment Income - Non-Operating |
0.8 |
-0.3 |
0.4 |
-0.3 |
0.5 |
|
Interest Income (Expense) - Net Non-Operating Total |
0.5 |
-0.6 |
0.1 |
-0.5 |
0.2 |
|
Gain (Loss) on Sale of Assets |
0.8 |
0.0 |
- |
0.0 |
0.2 |
|
Other Non-Operating Income (Expense) |
0.3 |
0.3 |
-1.3 |
-1.0 |
0.6 |
|
Other, Net |
0.3 |
0.3 |
-1.3 |
-1.0 |
0.6 |
|
Income Before Tax |
4.9 |
5.2 |
3.7 |
9.2 |
13.6 |
|
|
|
|
|
|
|
|
Total Income Tax |
2.8 |
1.9 |
1.2 |
3.3 |
4.7 |
|
Income After Tax |
2.0 |
3.3 |
2.4 |
5.9 |
8.9 |
|
|
|
|
|
|
|
|
Minority Interest |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Net Income Before Extraord Items |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
Net Income |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Miscellaneous Earnings Adjustment |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Total Adjustments to Net Income |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Income Available to Common Excl Extraord Items |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Income Available to Common Incl Extraord Items |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Basic/Primary Weighted Average Shares |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Basic EPS Excl Extraord Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Basic/Primary EPS Incl Extraord Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Dilution Adjustment |
- |
0.0 |
0.0 |
0.0 |
0.0 |
|
Diluted Net Income |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
Diluted Weighted Average Shares |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Diluted EPS Excl Extraord Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Diluted EPS Incl Extraord Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Dividends per Share - Common Stock Primary Issue |
0.09 |
0.11 |
0.10 |
0.09 |
0.08 |
|
Gross Dividends - Common Stock |
2.2 |
2.6 |
2.4 |
2.2 |
1.9 |
|
Interest Expense, Supplemental |
0.3 |
0.3 |
0.3 |
0.2 |
0.3 |
|
Depreciation, Supplemental |
20.2 |
18.2 |
14.3 |
11.9 |
11.1 |
|
Total Special Items |
-0.5 |
0.3 |
0.8 |
3.0 |
3.8 |
|
Normalized Income Before Tax |
4.4 |
5.5 |
4.5 |
12.2 |
17.4 |
|
|
|
|
|
|
|
|
Effect of Special Items on Income Taxes |
-0.3 |
0.1 |
0.3 |
1.1 |
1.3 |
|
Inc Tax Ex Impact of Sp Items |
2.5 |
2.0 |
1.5 |
4.3 |
6.0 |
|
Normalized Income After Tax |
1.8 |
3.5 |
2.9 |
7.8 |
11.3 |
|
|
|
|
|
|
|
|
Normalized Inc. Avail to Com. |
1.8 |
3.5 |
3.0 |
7.8 |
11.3 |
|
|
|
|
|
|
|
|
Basic Normalized EPS |
0.07 |
0.14 |
0.12 |
0.32 |
0.46 |
|
Diluted Normalized EPS |
0.07 |
0.14 |
0.12 |
0.32 |
0.46 |
|
Rental Expenses |
1.5 |
1.4 |
1.4 |
1.3 |
1.2 |
|
Research & Development Exp, Supplemental |
11.1 |
9.7 |
10.2 |
9.0 |
7.8 |
|
Reported Operating Profit |
3.6 |
5.9 |
5.7 |
13.6 |
18.0 |
|
Reported Ordinary Profit |
4.9 |
5.2 |
3.7 |
11.3 |
16.7 |
|
Normalized EBIT |
3.6 |
5.9 |
5.7 |
13.6 |
16.5 |
|
Normalized EBITDA |
23.8 |
24.0 |
20.0 |
25.5 |
27.6 |
|
Current Tax - Total |
0.8 |
- |
- |
- |
- |
|
Current Tax - Total |
0.8 |
- |
- |
- |
- |
|
Deferred Tax - Total |
2.0 |
- |
- |
- |
- |
|
Deferred Tax - Total |
2.0 |
- |
- |
- |
- |
|
Income Tax - Total |
2.8 |
- |
- |
- |
- |
|
Interest Cost - Domestic |
0.3 |
0.3 |
0.3 |
0.4 |
0.4 |
|
Service Cost - Domestic |
1.0 |
1.0 |
1.0 |
0.9 |
0.8 |
|
Prior Service Cost - Domestic |
- |
- |
- |
0.0 |
0.0 |
|
Actuarial Gains and Losses - Domestic |
0.1 |
0.0 |
0.1 |
0.0 |
0.1 |
|
Other Pension, Net - Domestic |
0.6 |
0.6 |
- |
- |
- |
|
Domestic Pension Plan Expense |
2.0 |
1.9 |
1.4 |
1.3 |
1.2 |
|
Defined Contribution Expense - Domestic |
0.6 |
0.5 |
0.4 |
0.2 |
0.2 |
|
Total Pension Expense |
2.7 |
2.4 |
1.8 |
1.5 |
1.4 |
|
Discount Rate - Domestic |
1.40% |
1.40% |
1.80% |
1.80% |
2.50% |
|
Expected Rate of Return - Domestic |
- |
- |
- |
- |
3.00% |
|
Total Plan Interest Cost |
0.3 |
0.3 |
0.3 |
0.4 |
0.4 |
|
Total Plan Service Cost |
1.0 |
1.0 |
1.0 |
0.9 |
0.8 |
|
Total Plan Other Expense |
0.6 |
0.6 |
- |
- |
- |
Annual Balance Sheet
Financials in: USD (mil)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate |
82.385362 |
82.88 |
93.44 |
98.77 |
99.535 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Cash & Equivalents |
5.0 |
3.6 |
2.4 |
3.7 |
5.4 |
|
Cash and Short Term Investments |
5.0 |
3.6 |
2.4 |
3.7 |
5.4 |
|
Accounts Receivable -
Trade, Gross |
66.0 |
63.9 |
63.6 |
55.0 |
62.2 |
|
Provision for Doubtful
Accounts |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
Trade Accounts Receivable - Net |
65.7 |
63.6 |
63.3 |
54.7 |
62.0 |
|
Total Receivables, Net |
65.7 |
63.6 |
63.3 |
54.7 |
62.0 |
|
Inventories - Finished Goods |
37.5 |
29.6 |
26.7 |
36.9 |
35.9 |
|
Inventories - Work In Progress |
10.4 |
7.4 |
7.7 |
12.2 |
10.2 |
|
Inventories - Raw Materials |
7.9 |
9.7 |
6.6 |
6.7 |
5.6 |
|
Total Inventory |
55.8 |
46.7 |
41.1 |
55.8 |
51.7 |
|
Deferred Income Tax - Current Asset |
1.3 |
1.2 |
1.8 |
1.9 |
3.3 |
|
Other Current Assets |
1.2 |
0.6 |
0.9 |
0.7 |
3.7 |
|
Other Current Assets, Total |
2.5 |
1.8 |
2.6 |
2.6 |
7.0 |
|
Total Current Assets |
129.0 |
115.7 |
109.5 |
116.9 |
126.1 |
|
|
|
|
|
|
|
|
Property/Plant/Equipment - Net |
116.4 |
127.2 |
114.0 |
86.1 |
77.0 |
|
Intangibles, Net |
0.4 |
0.5 |
0.6 |
0.8 |
1.1 |
|
LT Investment - Affiliate Companies |
0.4 |
0.4 |
0.4 |
- |
- |
|
LT Investments - Other |
14.0 |
15.0 |
14.3 |
11.5 |
14.8 |
|
Long Term Investments |
14.4 |
15.4 |
14.7 |
11.5 |
14.8 |
|
Note Receivable - Long Term |
- |
- |
0.0 |
0.0 |
0.5 |
|
Deferred Income Tax - Long Term Asset |
5.2 |
6.2 |
5.6 |
6.8 |
4.4 |
|
Other Long Term Assets |
1.5 |
1.8 |
1.9 |
1.6 |
1.8 |
|
Other Long Term Assets, Total |
6.7 |
8.0 |
7.5 |
8.4 |
6.2 |
|
Total Assets |
266.9 |
266.9 |
246.2 |
223.7 |
225.8 |
|
|
|
|
|
|
|
|
Accounts Payable |
46.3 |
42.0 |
42.1 |
43.5 |
52.6 |
|
Accrued Expenses |
1.3 |
1.4 |
1.4 |
1.4 |
1.5 |
|
Notes Payable/Short Term Debt |
27.8 |
29.7 |
19.4 |
19.3 |
5.8 |
|
Current Portion - Long Term Debt/Capital Leases |
- |
1.6 |
1.4 |
1.3 |
- |
|
Income Taxes Payable |
1.1 |
0.9 |
0.7 |
0.8 |
5.5 |
|
Other Current Liabilities |
11.5 |
10.0 |
19.6 |
9.8 |
13.2 |
|
Other Current liabilities, Total |
12.6 |
10.9 |
20.4 |
10.6 |
18.7 |
|
Total Current Liabilities |
88.0 |
85.5 |
84.6 |
76.2 |
78.6 |
|
|
|
|
|
|
|
|
Long Term Debt |
2.5 |
4.1 |
5.0 |
0.0 |
1.3 |
|
Total Long Term Debt |
2.5 |
4.1 |
5.0 |
0.0 |
1.3 |
|
Total Debt |
30.3 |
35.3 |
25.8 |
20.7 |
7.1 |
|
|
|
|
|
|
|
|
Minority Interest |
0.4 |
0.4 |
0.3 |
0.3 |
0.3 |
|
Pension Benefits - Underfunded |
17.5 |
18.4 |
17.1 |
17.0 |
18.7 |
|
Other Long Term Liabilities |
5.4 |
5.6 |
3.5 |
3.5 |
2.9 |
|
Other Liabilities, Total |
22.9 |
24.0 |
20.7 |
20.5 |
21.6 |
|
Total Liabilities |
113.8 |
114.0 |
110.7 |
97.0 |
101.8 |
|
|
|
|
|
|
|
|
Common Stock |
28.4 |
28.3 |
25.1 |
23.7 |
23.5 |
|
Common Stock |
28.4 |
28.3 |
25.1 |
23.7 |
23.5 |
|
Additional Paid-In Capital |
18.8 |
18.7 |
16.6 |
15.7 |
15.6 |
|
Retained Earnings (Accumulated Deficit) |
98.5 |
98.6 |
86.8 |
82.0 |
77.6 |
|
Treasury Stock - Common |
-0.1 |
-0.1 |
-0.1 |
-0.1 |
-0.1 |
|
Unrealized Gain (Loss) |
7.5 |
7.4 |
7.1 |
5.3 |
7.3 |
|
Other Equity |
0.0 |
- |
- |
- |
- |
|
Other Equity, Total |
0.0 |
- |
- |
- |
- |
|
Total Equity |
153.1 |
152.9 |
135.5 |
126.7 |
124.0 |
|
|
|
|
|
|
|
|
Total Liabilities & Shareholders’ Equity |
266.9 |
266.9 |
246.2 |
223.7 |
225.8 |
|
|
|
|
|
|
|
|
Shares Outstanding - Common Stock Primary
Issue |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Total Common Shares Outstanding |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Treasury Shares - Common Stock Primary Issue |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Employees |
342 |
335 |
326 |
350 |
337 |
|
Number of Common Shareholders |
1,364 |
1,328 |
1,222 |
1,177 |
1,141 |
|
Total Long Term Debt, Supplemental |
4.1 |
9.2 |
6.4 |
1.3 |
4.0 |
|
Long Term Debt Maturing within 1 Year |
1.6 |
1.6 |
1.4 |
1.3 |
2.7 |
|
Long Term Debt Maturing in Year 2 |
1.6 |
1.6 |
1.4 |
- |
1.3 |
|
Long Term Debt Maturing in Year 3 |
0.9 |
1.6 |
1.4 |
- |
0.0 |
|
Long Term Debt Maturing in Year 4 |
- |
0.9 |
1.4 |
- |
- |
|
Long Term Debt Maturing in Year 5 |
- |
- |
0.8 |
- |
- |
|
Long Term Debt Maturing in 2-3 Years |
2.5 |
3.2 |
2.8 |
- |
1.3 |
|
Long Term Debt Maturing in 4-5 Years |
- |
0.9 |
2.2 |
- |
- |
|
Long Term Debt Matur. in Year 6 & Beyond |
0.0 |
3.6 |
0.0 |
0.0 |
0.0 |
|
Total Capital Leases, Supplemental |
0.2 |
0.2 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in Year 1 |
0.1 |
0.0 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in Year 2 |
0.1 |
0.0 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in Year 3 |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in Year 4 |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in Year 5 |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in 2-3 Years |
0.1 |
0.1 |
0.0 |
0.0 |
- |
|
Capital Lease Payments Due in 4-5 Years |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Cap. Lease Pymts. Due in Year 6 & Beyond |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Pension Obligation - Domestic |
18.4 |
19.0 |
17.5 |
17.6 |
17.2 |
|
Plan Assets - Domestic |
- |
- |
- |
- |
0.0 |
|
Funded Status - Domestic |
-18.4 |
-19.0 |
-17.5 |
-17.6 |
-17.2 |
|
Total Funded Status |
-18.4 |
-19.0 |
-17.5 |
-17.6 |
-17.2 |
|
Discount Rate - Domestic |
1.40% |
1.40% |
1.80% |
1.80% |
2.50% |
|
Expected Rate of Return - Domestic |
- |
- |
- |
- |
3.00% |
|
Accrued Liabilities - Domestic |
-17.5 |
-18.4 |
-17.1 |
-17.0 |
-17.7 |
|
Other Assets, Net - Domestic |
0.9 |
0.6 |
0.3 |
0.7 |
-0.5 |
|
Net Assets Recognized on Balance Sheet |
-16.6 |
-17.8 |
-16.8 |
-16.3 |
-18.2 |
|
Total Plan Obligations |
18.4 |
19.0 |
17.5 |
17.6 |
17.2 |
|
Total Plan Assets |
- |
- |
- |
- |
0.0 |
Annual Cash Flows
Financials in: USD (mil)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
12 Months |
12 Months |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate
(Period Average) |
78.961215 |
85.691434 |
92.941082 |
100.484331 |
114.302336 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Net Income/Starting Line |
4.9 |
5.2 |
3.7 |
9.2 |
13.6 |
|
Depreciation |
20.2 |
18.2 |
14.3 |
11.9 |
11.1 |
|
Depreciation/Depletion |
20.2 |
18.2 |
14.3 |
11.9 |
11.1 |
|
Unusual Items |
0.2 |
0.3 |
0.3 |
2.3 |
3.9 |
|
Other Non-Cash Items |
-1.6 |
-1.4 |
-1.1 |
-3.2 |
-0.5 |
|
Non-Cash Items |
-1.4 |
-1.2 |
-0.8 |
-0.9 |
3.4 |
|
Accounts Receivable |
-1.7 |
7.6 |
-5.6 |
7.6 |
-6.8 |
|
Inventories |
-9.2 |
-0.3 |
18.0 |
-3.6 |
0.9 |
|
Accounts Payable |
4.3 |
-5.4 |
-3.9 |
-9.3 |
6.9 |
|
Accrued Expenses |
-0.1 |
-0.2 |
-0.1 |
-0.1 |
0.1 |
|
Taxes Payable |
-0.9 |
0.7 |
0.2 |
-0.8 |
0.5 |
|
Other Operating Cash Flow |
1.3 |
-1.6 |
3.4 |
-10.6 |
0.2 |
|
Changes in Working Capital |
-6.3 |
0.8 |
12.0 |
-16.9 |
2.0 |
|
Cash from Operating Activities |
17.3 |
23.1 |
29.1 |
3.3 |
30.0 |
|
|
|
|
|
|
|
|
Purchase of Fixed Assets |
-7.6 |
-25.4 |
-31.9 |
-19.5 |
-9.0 |
|
Purchase/Acquisition of Intangibles |
-0.1 |
-0.3 |
-0.1 |
0.0 |
-0.1 |
|
Capital Expenditures |
-7.7 |
-25.7 |
-32.0 |
-19.6 |
-9.2 |
|
Sale of Fixed Assets |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Sale/Maturity of Investment |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Other Investing Cash Flow |
0.0 |
0.1 |
-0.4 |
0.5 |
0.7 |
|
Other Investing Cash Flow Items, Total |
0.1 |
0.1 |
-0.3 |
0.5 |
0.7 |
|
Cash from Investing Activities |
-7.6 |
-25.5 |
-32.4 |
-19.0 |
-8.5 |
|
|
|
|
|
|
|
|
Other Financing Cash Flow |
0.0 |
0.0 |
- |
- |
- |
|
Financing Cash Flow Items |
0.0 |
0.0 |
- |
- |
- |
|
Cash Dividends Paid - Common |
-2.8 |
-2.6 |
-2.4 |
-2.2 |
-1.3 |
|
Total Cash Dividends Paid |
-2.8 |
-2.6 |
-2.4 |
-2.2 |
-1.3 |
|
Repurchase/Retirement
of Common |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Common Stock, Net |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Issuance (Retirement) of Stock, Net |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Short Term Debt, Net |
-3.8 |
7.6 |
-1.1 |
15.9 |
-4.4 |
|
Long Term Debt Issued |
- |
0.0 |
6.5 |
0.0 |
0.0 |
|
Long Term Debt
Reduction |
-1.7 |
-1.5 |
-1.4 |
-2.7 |
-10.8 |
|
Long Term Debt, Net |
-1.7 |
-1.5 |
5.1 |
-2.7 |
-10.8 |
|
Issuance (Retirement) of Debt, Net |
-5.5 |
6.1 |
4.0 |
13.3 |
-15.2 |
|
Cash from Financing Activities |
-8.3 |
3.5 |
1.6 |
11.1 |
-16.5 |
|
|
|
|
|
|
|
|
Foreign Exchange Effects |
0.1 |
-0.1 |
0.1 |
-0.1 |
-0.2 |
|
Net Change in Cash |
1.5 |
0.9 |
-1.6 |
-4.7 |
4.8 |
|
|
|
|
|
|
|
|
Net Cash - Beginning Balance |
3.8 |
2.6 |
4.0 |
8.4 |
2.5 |
|
Net Cash - Ending Balance |
5.3 |
3.5 |
2.4 |
3.7 |
7.4 |
|
Cash Interest Paid |
0.3 |
0.3 |
0.3 |
0.2 |
0.3 |
|
Cash Taxes Paid |
0.6 |
0.5 |
0.6 |
7.5 |
0.2 |
Annual Income Statement
Financials in: USD (mil)
Except for share items (millions) and per share items (actual units)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
12 Months |
12 Months |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate
(Period Average) |
78.961215 |
85.691434 |
92.941082 |
100.484331 |
114.302336 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Total net sales |
249.6 |
232.8 |
221.7 |
234.7 |
218.9 |
|
Total Revenue |
249.6 |
232.8 |
221.7 |
234.7 |
218.9 |
|
|
|
|
|
|
|
|
Selling General And Administrative Expen |
0.3 |
- |
- |
- |
- |
|
Rounding adjustment Income Statement |
0.0 |
- |
- |
- |
- |
|
Total Cost of Sales |
205.9 |
189.2 |
179.2 |
187.4 |
171.0 |
|
Other Other SGA |
9.8 |
- |
- |
- |
- |
|
Other Selling/General/Admin. Expense |
0.0 |
- |
- |
- |
- |
|
Shipment expenses |
7.1 |
7.1 |
6.2 |
5.7 |
5.6 |
|
Retirement benefits |
1.0 |
- |
- |
- |
- |
|
Selling General And Administrative Expen |
0.3 |
- |
- |
- |
- |
|
Other Labor & Related Expenses -SGA |
9.5 |
- |
- |
- |
- |
|
Salaries&Bonus |
- |
9.0 |
8.5 |
8.1 |
6.6 |
|
Rent expenses |
1.5 |
1.4 |
1.4 |
1.3 |
1.2 |
|
Research&Development |
10.7 |
9.5 |
10.2 |
9.0 |
7.8 |
|
Other SGA Expenses |
- |
10.7 |
10.6 |
9.5 |
8.6 |
|
SP G on transfer defined benefits |
- |
- |
- |
- |
0.0 |
|
SP L on Impairment |
- |
- |
0.0 |
2.1 |
3.1 |
|
NOP Write-down Inventory |
- |
- |
- |
0.0 |
1.5 |
|
NOP Revalue.-Inventory |
- |
- |
- |
- |
0.0 |
|
Loss on valuation of investment securiti |
0.1 |
- |
- |
- |
- |
|
NOP L valuation of investment securiti |
- |
0.0 |
- |
- |
- |
|
NOP Write-off Fix. Asset |
0.2 |
0.3 |
0.8 |
0.9 |
0.9 |
|
Total Operating Expense |
246.4 |
227.3 |
216.8 |
224.1 |
206.3 |
|
|
|
|
|
|
|
|
Gain On Sales Of Goods |
0.8 |
- |
- |
- |
- |
|
SP L on liquid. of fixed assets |
- |
- |
- |
- |
0.0 |
|
NOP Interest Income |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
NOP Dividends Received |
0.9 |
0.8 |
0.7 |
0.8 |
0.4 |
|
Other Non-Operating Income (Expense) |
0.0 |
- |
- |
- |
- |
|
NOP Compensation Rcvd. |
0.3 |
0.2 |
0.2 |
0.4 |
1.0 |
|
NOP Sales Gain-Goods |
- |
0.0 |
- |
0.0 |
0.2 |
|
NOP Other Non-Operating Income |
0.3 |
0.2 |
0.1 |
0.3 |
0.2 |
|
NOP Interest Expenses |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
NOP Manufact. Halt Loss |
- |
0.0 |
-1.4 |
-1.3 |
0.0 |
|
NOP Foreign Exchange Losses |
-0.1 |
-1.1 |
-0.3 |
-1.1 |
0.0 |
|
NOP Other Non-Operating Expenses |
-0.2 |
-0.2 |
-0.4 |
-0.4 |
-0.6 |
|
Net Income Before Taxes |
4.9 |
5.2 |
3.7 |
9.2 |
13.6 |
|
|
|
|
|
|
|
|
Total income taxes |
2.8 |
1.9 |
1.2 |
3.3 |
4.7 |
|
Net Income After Taxes |
2.0 |
3.3 |
2.4 |
5.9 |
8.9 |
|
|
|
|
|
|
|
|
Minority interests in income |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Net Income Before Extra. Items |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
Net Income |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Miscellaneous Earnings Adjustment |
0.0 |
- |
- |
- |
- |
|
Adjustment |
- |
0.0 |
0.0 |
0.0 |
0.0 |
|
Directors' Bonuses |
- |
- |
- |
0.0 |
- |
|
Income Available to Com Excl ExtraOrd |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Income Available to Com Incl ExtraOrd |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
|
|
|
|
|
|
|
Basic Weighted Average Shares |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Basic EPS Excluding ExtraOrdinary Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Basic EPS Including ExtraOrdinary Item |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Dilution Adjustment |
- |
0.0 |
0.0 |
0.0 |
0.0 |
|
Diluted Net Income |
2.0 |
3.3 |
2.4 |
5.9 |
8.8 |
|
Diluted Weighted Average Shares |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Diluted EPS Excluding ExtraOrd Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
Diluted EPS Including ExtraOrd Items |
0.08 |
0.14 |
0.10 |
0.24 |
0.36 |
|
DPS-Common Stock |
0.09 |
0.11 |
0.10 |
0.09 |
0.08 |
|
Gross Dividends - Common Stock |
2.2 |
2.6 |
2.4 |
2.2 |
1.9 |
|
Normalized Income Before Taxes |
4.4 |
5.5 |
4.5 |
12.2 |
17.4 |
|
|
|
|
|
|
|
|
Inc Tax Ex Impact of Sp Items |
2.5 |
2.0 |
1.5 |
4.3 |
6.0 |
|
Normalized Income After Taxes |
1.8 |
3.5 |
2.9 |
7.8 |
11.3 |
|
|
|
|
|
|
|
|
Normalized Inc. Avail to Com. |
1.8 |
3.5 |
3.0 |
7.8 |
11.3 |
|
|
|
|
|
|
|
|
Basic Normalized EPS |
0.07 |
0.14 |
0.12 |
0.32 |
0.46 |
|
Diluted Normalized EPS |
0.07 |
0.14 |
0.12 |
0.32 |
0.46 |
|
Research and Development Expenses-SGA |
10.7 |
- |
- |
- |
- |
|
Research And Development Expense-COGS |
0.4 |
9.5 |
10.2 |
9.0 |
7.8 |
|
Research & Development Exp(COGS) |
- |
0.1 |
0.0 |
- |
- |
|
Interest Expense |
0.3 |
0.3 |
0.3 |
0.2 |
0.3 |
|
Rental Expense |
1.5 |
1.4 |
1.4 |
1.3 |
1.2 |
|
Amort of Tangible Assets-Current Portion |
20.2 |
- |
- |
- |
- |
|
Depreciation |
- |
18.2 |
14.3 |
11.9 |
11.1 |
|
Income taxes-current |
0.8 |
- |
- |
- |
- |
|
Current Tax - Total |
0.8 |
- |
- |
- |
- |
|
Income taxes-deferred |
2.0 |
- |
- |
- |
- |
|
Deferred Tax - Total |
2.0 |
- |
- |
- |
- |
|
Income Tax - Total |
2.8 |
- |
- |
- |
- |
|
Reported Operating Profit |
3.6 |
5.9 |
5.7 |
13.6 |
18.0 |
|
Reported Ordinary Profit |
4.9 |
5.2 |
3.7 |
11.3 |
16.7 |
|
Service Cost |
1.0 |
1.0 |
1.0 |
0.9 |
0.8 |
|
Interest Cost |
0.3 |
0.3 |
0.3 |
0.4 |
0.4 |
|
Actuarial Gains and Losses |
0.1 |
0.0 |
0.1 |
0.0 |
0.1 |
|
Prior Service Cost |
- |
- |
- |
0.0 |
0.0 |
|
Other Pension, Net - Domestic |
0.6 |
0.6 |
- |
- |
- |
|
Domestic Pension Plan Expense |
2.0 |
1.9 |
1.4 |
1.3 |
1.2 |
|
Defined Contribution Expenses |
0.6 |
0.5 |
0.4 |
0.2 |
0.2 |
|
Total Pension Expense |
2.7 |
2.4 |
1.8 |
1.5 |
1.4 |
|
Discount Rate(MIN)-Retirement Cost(Domes |
1.40% |
- |
- |
- |
- |
|
Discount Rate |
- |
1.40% |
1.80% |
1.80% |
2.50% |
|
Expected Rate of Return |
- |
- |
- |
- |
3.00% |
Annual Balance Sheet
Financials in: USD (mil)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate |
82.385362 |
82.88 |
93.44 |
98.77 |
99.535 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Cash and deposits |
5.0 |
3.6 |
2.4 |
3.7 |
5.4 |
|
Notes and accounts receivable-trade |
66.0 |
63.9 |
63.6 |
55.0 |
62.2 |
|
Merchandise and finished goods |
37.5 |
29.6 |
26.7 |
36.9 |
35.9 |
|
Work in process |
10.4 |
7.4 |
7.7 |
12.2 |
10.2 |
|
Raw materials and supplies |
7.9 |
9.7 |
6.6 |
6.7 |
5.6 |
|
Deferred tax assets |
1.3 |
1.2 |
1.8 |
1.9 |
3.3 |
|
Rounding adjustment Assets |
0.0 |
- |
- |
- |
- |
|
Other |
1.2 |
0.6 |
0.9 |
0.7 |
3.7 |
|
Allowance for doubtful accounts |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
Total Current Assets |
129.0 |
115.7 |
109.5 |
116.9 |
126.1 |
|
|
|
|
|
|
|
|
Other Total PPE, Net |
0.0 |
- |
- |
- |
- |
|
Buildings and structures, net |
55.3 |
56.3 |
51.7 |
28.9 |
30.4 |
|
Machinery, equipment and vehicles, net |
53.8 |
64.5 |
53.7 |
41.5 |
41.1 |
|
Land |
1.2 |
1.2 |
1.1 |
1.0 |
1.0 |
|
Construction in progress |
2.1 |
0.3 |
2.5 |
11.6 |
1.1 |
|
Other, net |
4.0 |
4.9 |
5.0 |
3.2 |
3.3 |
|
Other Total Intangible Assets, Net |
0.0 |
- |
- |
- |
- |
|
Software |
0.4 |
0.5 |
0.5 |
0.8 |
1.1 |
|
Right of using facilities |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
|
Othr LT Investment |
14.0 |
- |
- |
- |
- |
|
Investment securities |
- |
15.0 |
14.3 |
11.5 |
14.8 |
|
Invt Secs Noncons, Asc, Affd Cos |
0.4 |
- |
- |
- |
- |
|
Investment securities of non-con. afflt. |
- |
0.4 |
0.4 |
- |
- |
|
Deferred tax assets |
5.2 |
6.2 |
5.6 |
6.8 |
4.4 |
|
LT Loans |
- |
- |
0.0 |
0.0 |
0.5 |
|
Rounding adjustment Assets |
0.0 |
- |
- |
- |
- |
|
Other Other Long Term Assets |
0.0 |
- |
- |
- |
- |
|
Other |
1.6 |
1.9 |
2.0 |
1.7 |
2.6 |
|
Allowance for doubtful accounts |
-0.1 |
-0.1 |
-0.1 |
-0.1 |
-0.8 |
|
Adjustment |
- |
0.0 |
0.0 |
0.0 |
0.0 |
|
Total Assets |
266.9 |
266.9 |
246.2 |
223.7 |
225.8 |
|
|
|
|
|
|
|
|
Notes and accounts payable-trade |
46.3 |
42.0 |
42.1 |
43.5 |
52.6 |
|
Short-term loans payable |
27.8 |
29.7 |
19.4 |
19.3 |
5.8 |
|
LT Borrowings (current) |
- |
1.6 |
1.4 |
1.3 |
- |
|
Income taxes payable |
1.1 |
0.9 |
0.7 |
0.8 |
5.5 |
|
Provision for bonuses |
1.3 |
1.4 |
1.4 |
1.4 |
1.4 |
|
Reserve for directors' bonuses |
- |
- |
- |
0.0 |
0.2 |
|
Rounding adjustment Liability |
0.0 |
- |
- |
- |
- |
|
Other |
11.5 |
10.0 |
19.6 |
9.8 |
13.2 |
|
Total Current Liabilities |
88.0 |
85.5 |
84.6 |
76.2 |
78.6 |
|
|
|
|
|
|
|
|
Long-term loans payable |
2.5 |
4.1 |
5.0 |
0.0 |
1.3 |
|
Total Long Term Debt |
2.5 |
4.1 |
5.0 |
0.0 |
1.3 |
|
|
|
|
|
|
|
|
Rounding adjustment Liability |
0.0 |
- |
- |
- |
- |
|
Provision for retirement benefits |
17.5 |
18.4 |
17.1 |
17.0 |
17.7 |
|
Res-Direc.Retire |
- |
- |
- |
0.0 |
1.0 |
|
Long-term deposits received |
3.4 |
3.6 |
3.1 |
3.0 |
2.9 |
|
Other |
2.1 |
2.0 |
0.4 |
0.6 |
0.0 |
|
Minority interests |
0.4 |
0.4 |
0.3 |
0.3 |
0.3 |
|
Total Liabilities |
113.8 |
114.0 |
110.7 |
97.0 |
101.8 |
|
|
|
|
|
|
|
|
Rounding adjustment Equity |
0.0 |
- |
- |
- |
- |
|
Common Stock |
28.4 |
28.3 |
25.1 |
23.7 |
23.5 |
|
Total capital surpluses |
18.8 |
18.7 |
16.6 |
15.7 |
15.6 |
|
Total retained earnings |
98.5 |
98.6 |
86.8 |
82.0 |
77.6 |
|
Valuation difference on available-for-sa |
7.5 |
7.4 |
7.1 |
5.3 |
7.3 |
|
Deferred hedge gain/loss |
- |
- |
- |
0.0 |
0.0 |
|
Treasury stock |
-0.1 |
-0.1 |
-0.1 |
-0.1 |
-0.1 |
|
Total Equity |
153.1 |
152.9 |
135.5 |
126.7 |
124.0 |
|
|
|
|
|
|
|
|
Total Liabilities & Shareholders' Equity |
266.9 |
266.9 |
246.2 |
223.7 |
225.8 |
|
|
|
|
|
|
|
|
S/O-Common Stock |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
Total Common Shares Outstanding |
24.5 |
24.5 |
24.5 |
24.5 |
24.5 |
|
T/S-Common Stock |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Full-Time Employees |
342 |
335 |
326 |
350 |
337 |
|
Total Number of Shareholders |
1,364 |
- |
- |
- |
- |
|
Number of Common Shareholders |
- |
1,328 |
1,222 |
1,177 |
1,141 |
|
Long Term Debt Maturing Within 1 Year |
1.6 |
1.6 |
1.4 |
1.3 |
2.7 |
|
Lns Pble Maturing over a Yr within 2 Yrs |
1.6 |
- |
- |
- |
- |
|
Long Term Debt Maturing Within 2 Year |
- |
1.6 |
1.4 |
- |
1.3 |
|
Lns Pble Maturg over 2 Yrs within 3 Yrs |
0.9 |
- |
- |
- |
- |
|
Long Term Debt Maturing Within 3 Year |
- |
1.6 |
1.4 |
- |
0.0 |
|
Long Term Debt Maturing in Year 4 |
- |
0.9 |
1.4 |
- |
- |
|
Long Term Debt Maturing in Year 5 |
- |
- |
0.8 |
- |
- |
|
Long Term Debt - Remaining Maturities |
- |
3.6 |
- |
- |
- |
|
Total Long Term Debt, Supplemental |
4.1 |
9.2 |
6.4 |
1.3 |
4.0 |
|
Capital Lease Payments Due within 1 Year |
0.1 |
0.0 |
0.0 |
0.0 |
- |
|
Cap Lease Maturg over a Yr within 2 Yrs |
0.1 |
- |
- |
- |
- |
|
Capital Lease Payments Due in Year 2 |
- |
0.0 |
0.0 |
0.0 |
- |
|
Cap Lease Maturg over 2 Yr within 3 Yrs |
0.0 |
- |
- |
- |
- |
|
Capital Lease Payments Due in Year 3 |
- |
0.0 |
0.0 |
0.0 |
- |
|
Cap Lease Maturg over 3 Yr within 4 Yrs |
0.0 |
- |
- |
- |
- |
|
Capital Lease Payments Due in Year 4 |
- |
0.0 |
0.0 |
0.0 |
- |
|
Cap Lease Maturg over 4 Yr within 5 Yrs |
0.0 |
- |
- |
- |
- |
|
Capital Lease Payments Due in Year 5 |
- |
0.0 |
0.0 |
0.0 |
- |
|
Other Lease Remaing |
0.0 |
- |
- |
- |
- |
|
Capital Lease - Remaining Maturities |
- |
0.0 |
0.0 |
0.0 |
- |
|
Total Capital Leases |
0.2 |
0.2 |
0.0 |
0.0 |
- |
|
Pension Obligation |
18.4 |
19.0 |
17.5 |
17.6 |
17.2 |
|
Fair Value of Plan Assets |
- |
- |
- |
- |
0.0 |
|
Funded Status |
-18.4 |
-19.0 |
-17.5 |
-17.6 |
-17.2 |
|
Total Funded Status |
-18.4 |
-19.0 |
-17.5 |
-17.6 |
-17.2 |
|
Discount Rate |
1.40% |
1.40% |
1.80% |
1.80% |
2.50% |
|
Expected Rate of Return |
- |
- |
- |
- |
3.00% |
|
Unrecognized Actuarial Gains and Losses |
0.9 |
0.6 |
0.3 |
0.7 |
-0.4 |
|
Unrecognized Prior Service Cost |
- |
- |
- |
0.0 |
0.0 |
|
Reserve for Accrued Retirement Benefits |
-17.5 |
-18.4 |
-17.1 |
-17.0 |
-17.7 |
|
Net Assets Recognized on Balance Sheet |
-16.6 |
-17.8 |
-16.8 |
-16.3 |
-18.2 |
Annual Cash Flows
Financials in: USD (mil)
|
|
31-Mar-2012 |
31-Mar-2011 |
31-Mar-2010 |
31-Mar-2009 |
31-Mar-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
12 Months |
12 Months |
|
UpdateType/Date |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
Updated Normal |
|
Filed Currency |
JPY |
JPY |
JPY |
JPY |
JPY |
|
Exchange Rate
(Period Average) |
78.961215 |
85.691434 |
92.941082 |
100.484331 |
114.302336 |
|
Auditor |
KPMG AZSA LLC |
KPMG LLP |
KPMG LLP |
KPMG LLP |
KPMG LLP |
|
Auditor Opinion |
Unqualified |
Unqualified |
Unqualified |
Unqualified with
Explanation |
Unqualified |
|
|
|
|
|
|
|
|
Income Before Tax |
4.9 |
5.2 |
3.7 |
9.2 |
13.6 |
|
Depreciation |
20.2 |
18.2 |
14.3 |
11.9 |
11.1 |
|
Asset Sold&Retired |
- |
- |
- |
- |
0.8 |
|
Loss (gain) on valuation of investment s |
0.1 |
- |
- |
- |
- |
|
Loss on retirement of property, plant an |
0.1 |
0.3 |
0.3 |
0.2 |
- |
|
Impairement |
- |
- |
0.0 |
2.1 |
3.1 |
|
G/L on val. LT inv't in secs. |
- |
0.0 |
0.0 |
0.0 |
0.0 |
|
Increase (decrease) in allowance for dou |
0.0 |
0.0 |
0.1 |
-0.7 |
0.0 |
|
Res-Dir's Bonus Allowance |
- |
- |
0.0 |
-0.1 |
0.0 |
|
Increase (decrease) in provision for ret |
-1.1 |
-0.9 |
-0.8 |
-0.8 |
-0.3 |
|
Increase (decrease) in provision for bon |
-0.1 |
-0.2 |
-0.1 |
0.0 |
0.1 |
|
Res-Direc.Retire Bft |
- |
- |
0.0 |
-1.0 |
0.0 |
|
Int. and Div. Income |
-0.9 |
-0.8 |
-0.7 |
-0.8 |
-0.5 |
|
Interest expenses |
0.3 |
0.3 |
0.3 |
0.2 |
0.3 |
|
Decrease (increase) in notes and account |
-1.7 |
7.6 |
-5.6 |
7.6 |
-6.8 |
|
Decrease (increase) in inventories |
-9.2 |
-0.3 |
18.0 |
-3.6 |
0.9 |
|
Increase (decrease) in notes and account |
4.3 |
-5.4 |
-3.9 |
-9.3 |
6.9 |
|
Increase (decrease) in accrued consumpti |
-0.9 |
0.7 |
0.2 |
-0.8 |
0.5 |
|
Director Bonus Paid |
- |
- |
- |
- |
0.0 |
|
Other, net |
1.4 |
-1.6 |
3.5 |
-3.7 |
0.2 |
|
Int. and Div. Rcvd. |
0.9 |
0.8 |
0.7 |
0.8 |
0.5 |
|
Interest expenses paid |
-0.3 |
-0.3 |
-0.3 |
-0.2 |
-0.3 |
|
Income taxes (paid) refund |
-0.6 |
-0.5 |
-0.6 |
-7.5 |
-0.2 |
|
Adjustment |
- |
0.0 |
- |
- |
- |
|
Cash from Operating Activities |
17.3 |
23.1 |
29.1 |
3.3 |
30.0 |
|
|
|
|
|
|
|
|
Purchase of property, plant and equipmen |
-7.6 |
-25.4 |
-31.9 |
-19.5 |
-9.0 |
|
Proceeds from sales of property, plant a |
0.0 |
0.0 |
0.0 |
0.0 |
- |
|
Purch.-Intang.Asset |
-0.1 |
-0.3 |
-0.1 |
0.0 |
-0.1 |
|
Redempt.-Invest. Sec |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Payments Of Loans Receivable |
-0.1 |
- |
- |
- |
- |
|
Rounding adjustment Cash flow |
0.0 |
- |
- |
- |
- |
|
Payments of loans receivable |
- |
0.0 |
0.0 |
-0.1 |
0.0 |
|
Loans Collected |
0.0 |
0.0 |
0.0 |
0.5 |
0.6 |
|
Other, net |
0.1 |
0.1 |
-0.4 |
0.0 |
0.1 |
|
Cash from Investing Activities |
-7.6 |
-25.5 |
-32.4 |
-19.0 |
-8.5 |
|
|
|
|
|
|
|
|
Net increase (decrease) in short-term lo |
-3.8 |
7.6 |
-1.1 |
15.9 |
-4.4 |
|
Issued-LT Debt |
- |
0.0 |
6.5 |
0.0 |
0.0 |
|
Rounding adjustment Cash flow |
0.0 |
- |
- |
- |
- |
|
Repayments of finance lease obligations |
- |
0.0 |
- |
- |
- |
|
Repayments Of Finance Lease Obligations |
-0.1 |
- |
- |
- |
- |
|
Repayment of long-term loans payable |
-1.7 |
-1.5 |
-1.4 |
-2.7 |
-10.8 |
|
Purchase of treasury stock |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Cash dividends paid |
-2.8 |
-2.6 |
-2.4 |
-2.2 |
-1.3 |
|
Cash from Financing Activities |
-8.3 |
3.5 |
1.6 |
11.1 |
-16.5 |
|
|
|
|
|
|
|
|
Foreign Exchange Effects |
0.1 |
-0.1 |
0.1 |
-0.1 |
-0.2 |
|
Net Change in Cash |
1.5 |
0.9 |
-1.6 |
-4.7 |
4.8 |
|
|
|
|
|
|
|
|
Net Cash - Beginning Balance |
3.8 |
2.6 |
4.0 |
8.4 |
2.5 |
|
Net Cash - Ending Balance |
5.3 |
3.5 |
2.4 |
3.7 |
7.4 |
|
Cash Interest Paid |
0.3 |
0.3 |
0.3 |
0.2 |
0.3 |
|
Cash Taxes Paid |
0.6 |
0.5 |
0.6 |
7.5 |
0.2 |
Financial
Health
Financials in: USD (mil)
Except for share items (millions) and per share items (actual units)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual Ratios
Financials in: USD (mil)
Except for share items (millions) and per share items (actual units)
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.77 |
|
UK Pound |
1 |
Rs.81.57 |
|
Euro |
1 |
Rs.70.68 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.